Stay updated on Pembrolizumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T16:38:39.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T19:24:05.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer identifies the ClinicalTrials.gov site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T19:19:27.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T20:09:08.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry (v3.7.0) and removes the previous revision (v3.6.6) from the visible history, updating the page's version trail.
    Difference
    0.1%
    Check dated 2026-09-19T20:52:21.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The Record History now shows a new version entry with updated study status and related data. Additions and deletions are highlighted to indicate what was changed on the record.
    Difference
    0.1%
    Check dated 2026-09-05T20:28:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.